Meeting
2022 ASCO Annual Meeting
Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
Authors
Jennifer Ma
Memorial Sloan Kettering Cancer Center, New York, NY
Jennifer Ma , Luke del Balzo , Sari Safaa Khaleel , Jessica Flynn , Zhigang Zhang , Martin H Voss , Benjamin Freeman , A. Ari Hakimi , Chung-Han Lee , Jordan Eichholz , Daniel W. Kelly , Jonathan T. Yang , Boris Mueller , Maria Isabel Carlo , Robert J. Motzer , Brandon S. Imber , Kathryn Beal , Nelson S. Moss , Ritesh Kotecha , Luke Roy George Pike
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4526)
DOI
10.1200/JCO.2022.40.16_suppl.4526
Abstract #
4526
Poster Bd #
17
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Characteristics and outcomes of patients managed with surgical resection of brain metastasis from renal cell carcinoma.
First Author: Max Drescher
Poster
2021 ASCO Annual Meeting
A phase II trial combining nivolumab and stereotactic brain radiosurgery for treatment of brain metastases in patients with NSCLC.
First Author: Philip Wong
Poster
2012 Genitourinary Cancers Symposium
The role of stereotactic radiosurgery in the treatment of renal cell carcinoma patients with five or more brain metastases.
First Author: Alireza Mohammad Mohammadi
Poster
2024 ASCO Annual Meeting
Treatment outcomes of brain metastasis from primary renal cell carcinoma in United States: A National Cancer Database analysis.
First Author: Vivek Podder